Angiotensin II signal transduction pathways

Regulatory Peptides

Volumn 78, Issue 1-3, 1998, Pages 19-29

  Sayeski, Peter P ^a   Ali, M Showkat ^a   Semeniuk, Dan J ^a   Doan, Thanh N ^a   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Effector molecule; Heterotrimeric G protein; Renin; Renin angiotensin system; Signal transduction pathways; Tyrosine phosphorylation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; TYROSINE;

HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANGIOTENSIN II; CELL ADHESION MOLECULES; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GTP-BINDING PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

EID: 0032583175     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00137-2     Document Type: Review

References (93)

1. [1] Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
2. 1 receptor. J Biol Chem 1997;272:23382-8.
3. [3] Ali MS, Schieffer B, Delafontaine P, Bernstein KE, Ling BE, Marrero MB. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein tyrosine phosphatase 1D in vascular smooth muscle cells. J Biol Chem 1997;272:12373-9.
4. [4] Bakhle YS. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung. Nature 1968;220:919-21.
5. [5] Barnard EA. Receptor classes and the transmitter-gated ion channels. Trends Pharm Sci 1992;17:368-74.
6. [6] Bhat GJ, Thekkumkara TJ, Thomas WG, Conrad KM, Baker KM. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. J Biol Chem 1994;269:31443-9.
7. 1A cells. J Biol Chem 1995;270:19059-65.
8. [8] Bhat GJ, Abraham ST, Singer HA, Baker KM. Alpha-thrombin stimulates sis-inducing factor-A DNA binding activity in rat aortic smooth muscle cells. Hyperten 1997;29:356-60.
9. [9] Bihoreau C, Monnot C, Davies E, Teusch B, Bernstein KE, Corvol P, Clauser E. Mutation of Asp74 of the rat angiotensin II receptor confers changes in antagonist affinities and abolishes G-protein coupling. Proc Natl Acad Sci USA 1993;90:5133-7.
10. [10] Bolen JR, Rowley RB, Spana C, Tsygankov AY. The src family of tyrosine kinases in hematopoietic signal transduction. FASEB J 1992;6:3403-9.
11. [11] Braun-Menendez E, Fasciolo E, Leloir JC, Munoz JM. The substance causing renal hypertension. J Physiol (London) 1940;98:283-98.
12. [12] Briscoe J, Kohlhuber F, Muller M. JAKS and STATS branch out. Trends Cell Biol 1996;6:336-40.
13. FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 1992;119:893-903.
14. [14] Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995;15:954-63.
15. [15] Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 1997;272:F299-304.
16. [16] Chiu AT, McCall DE, Nguyen TT, Carini DJ, Duncia JV, Herblin WF, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM. Discrimination of angiotensin II receptor subtypes by dithiothreitol. Eur J Pharm 1989;170:117-8.
17. [17] Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PBMWM. In vitro pharmacology of Dup753, an orally active anti-hypertensive agent. Am J Hypertens 1991;4:282S-7S.
18. 1A angiotensin receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal. J Biol Chem 1997;272:25566-72.
19. 1A receptor transduces an amplified Ang II signal. Am J Physiol (Endocrinol Metab 37) 1998;274:E336-45.
20. [20] Crawford KW, Frey EA, Cote TE. Angiotensin II receptor recognized by Dup753 regulates two distinct guanine nucleotide binding protein signaling pathways. Mol Pharm 1992;41:154-62.
21. [21] Du J, Sperling LS, Marrero MB, Phillips L, Delafontaine P. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth cells: thrombin and angiotensin II induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem Biophys Res Commun 1996;218:934-9.
22. [22] Duncia JV, Carini DJ, Chiu AT, Johnson AL, Price WA, Wong PC, Wexler RR, Timmermans PBMWM. The discovery of Dup753, a potent, orally active nonpeptide angiotensin II receptor antagonist. Med Res Rev 1992;12:149-91.
23. [23] Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 1995;7:176-82.
24. [24] Fischer EH, Krebs EG. Conversion of phosphorylase b to phosphorylase a in muscle extracts. J Biol Chem 1955;216:121-32.
25. [25] Furakawa Y, Kishimoto S, Nishikawa K, Hypotensive imidazole derivatives and hypotensive imidazole-5-acetic acid derivatives. Patents issued to Takeda Chemical Industries Ltd, July 20, 1982 and October 19, 1982, respectively, US Patents 4 340 598 and 4 355 040, Osaka, Japan.
26. [26] Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension II: The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934;59:347-79.
27. 1A angiotensin II receptor induces its constitutive activation. J Biol Chem 1997;272:1822-6.
28. [28] Hanke J H, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 1996;271:695-701.
29. [29] Hanks SK, Hunter T, The eukaryotic protein kinase superfamily. In: Hardie G, Hanks SK, editors. The Protein Kinase Factsbook. San Diego: Academic Press, 1995:7-47.
30. [30] Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature 1995;377:744-7.
31. 1 receptor. J Biol Chem 1994;269:30953-9.
32. [32] Hunyady L, Baukal AJ, Balla T, Catt KJ. Independence of type 1 angiotensin II receptor endocytocis from G protein coupling and signal transduction. J Biol Chem 1994;269:24798-804.
33. [33] Hunyady L, Bor M, Balla T, Catt KJ. Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. J Biol Chem 1994;269:31378-82.
34. [34] Hunyady L, Bor M, Balla T, Catt KJ. Critical role of a conserved intramembrane tyrosine residue in angiotensin II receptor activation. J Biol Chem 1995;270:9702-5.
35. [35] Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-50.
36. [36] Inagami T, Iwai N, Sasaki K, Yamano Y, Bardhan S, Chaki S, Guo DF, Furuta HJ. Cloning, expression and regulation of angiotensin II receptors. Hypertension 1992;10:713-6.
37. [37] Inoue Y, Nakamura N, Inagami T. A review of mutagenesis studies of angiotensin II type 1 receptor, the three dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J Hypertens 1997;15:703-14.
38. c-src in vascular smooth muscle cells. Circ Res 1995;77:1053-9.
39. [39] Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995;92:3521-5.
40. [40] Iwai N, Inagami T. Identification of two subtypes in the rat type 1 angiotensin II receptor. FEBS Lett 1992;298:257-60.
41. 1A receptors mapped with synthetic peptides selected from the receptor sequence. Biochem J 1998;332:781-7.
42. 11 alpha subunits in cultured vascular smooth muscle cells. Mol Pharm 1996;49:96-104.
43. [43] Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type 1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem Biophys Res Commun 1992;183:1090-6.
44. [44] Kambayashi Y, Bardhan S, Takahashi K, Tsuzuki S, Inui H, Hamakubo T, Inagami T. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993;263:24543-6.
45. [45] Kanner SB, Reynolds AB, Vines RR, Parsons JT. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 1990;87:3328-32.
46. [46] Leduc L, Meloche S. Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 1995;270:4401-4.
47. [47] Lentz KE, Skeggs LT, Marsh WH, Woods KR, Shumway NP. Amino acid composition of hypertesin II and its biochemical relationship to hypertensin I. J Exp Med 1956;104:183-91.
48. [48] Leszcynski D, Joenvarra S, Foegh ML. Protein kinase C-α regulates proliferation but not apoptosis in rat coronary vascular smooth muscle cells. Life Sci 1996;58:599-606.
49. [49] Li X, Earp HS. Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells. J Biol Chem 1997;272:14341-8.
50. [50] Linseman DA, Benjamin CW, Jones CA. Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 1995;270:12563-8.
51. 2+ in rat portal vein myocytes. J Biol Chem 1997;272:10095-102.
52. 1A angiotensin II receptor is essential for its coupling to phospholipase C. J Biol Chem 1994;269:20815-8.
53. [53] Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem 1994;269:10935-9.
54. c-src antibodies inhibits the angiotensin II activation of phospholipase c-γ1 in rat aortic muscle cells. J Biol Chem 1995;270:15734-8.
55. 1 receptor. Nature 1995;375:247-50.
56. [56] McWhinney CD, Hunt RA, Conrad CM, Dostal DE, Baker KM. The type 1 angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J Mol Cell Cardiol 1997;29:2513-24.
57. [57] Mukoyama M, Nakjima M, Horiuchi M, Sasamura H, Pratt RE, Dzau VJ. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993;268:24539-42.
58. [58] Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991;351:233-6.
59. [59] Ng KKF, Vane JR. Conversion of angiotensin I to angiotensin II. Nature 1967;216:762-6.
60. [60] Okuda K, Kawahara Y, Yokoyama M. Angiotensin II type-1 receptor-mediated activation of Ras in cultured rat vascular smooth muscle cells. Am J Physiol 1996;271:H595-601.
61. [61] Page IH, Helmer OM. A crystalline pressor substance (angiotonin) resulting from the reaction between renin and renin activator. J Exp Med 1940;71:29-42.
62. [62] Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998;93:385-95.
63. 1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the Src family of tyrosine kinases. Biochem Biophys Res Commun 1994;200:260-7.
64. [64] Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G. Somatic mutations in the thyrotropin receptor gene causes hyperfunctioning thyroid adenomas. Nature 1993;365:649-51.
65. A receptors. Biochem Biophys Res Commun 1996;221:62-6.
66. [66] Pimental EL. Protein Phosphorylation. In Pimental EL, editor. Growth Factors, vol. 1. Boca Raton, FL: CRC Press, 1994:207-266.
67. [67] Polte TR, Naftilan AJ, Hanks SK. Focal adhesion kinase is abundant in developing blood vessels and elevation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II. J Cell Biochem 1994;55:106-19.
68. [68] Rodriguez-Linares B, Watson SP. Phosphorylation of Jak2 in thrombin-stimulated human platelets. FEBS Lett 1994;352:335-8.
69. [69] Ryan US, Ryan JW, Whitaker C, Chiu A. Localization of angiotensin converting enzyme (kininase II). Immunohistochemistry and immunofluorescence. Tissue Cell 1976;8:125-45.
70. ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes. EMBO J 1996;15:775-87.
71. [71] Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H. A novel signaling molecule, p 130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 1994;13:3748-56.
72. [72] Sandberg K, Ji H, Clark AJL, Shapira H, Catt KJ. Cloning and expression of a novel angiotensin II receptor subtype. J Biol Chem 1992;267:9455-8.
73. [73] Sander GE, Huggins CG. Subcellular localization of angiotensin I converting enzyme in rabbit lung. Nat New Biol 1971;230:27-9.
74. [74] Sano T, Ohyama K, Yamano Y, Nakagomi Y, Nakazawa S, Kikyo M, Shirai H, Blank JS, Exton JH, Inagami T. A domain for G protein coupling in the carboxyl-terminal tail of rat angiotensin II receptor type 1A. J Biol Chem 1997;272:23631-6.
75. [75] Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary cDNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991;351:230-2.
76. 2+, and protein kinase C. Circ Res 1998;82:1279-88.
77. c-src. J Biol Chem 1996;271:10329-33.
78. [78] Schlaepfer DD, Hunter T. Focal adhesion kinase overexpression enhances Ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem 1997;272:13189-95.
79. [79] Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM. Angiotensin II-induced protein tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem 1994;269:19626-32.
80. [80] Shirai H, Takahashi K, Katada T, Inagami T. Mapping G protein coupling sites of the angiotensin II type 1 receptor. Hypertension 1995:726-730.
81. [81] Skeggs LT, Marsh WH, Kahn JR, Shumway NP. The purification of hypertensin I. J Exp Med 1954;100:363-70.
82. [82] Skeggs LT, Marsh WH, Kahn JR, Shumway NP. Amino acid composition and electrophoretic properties of hypertensin I. J Exp Med 1955;102:435-40.
83. [83] Skeggs LT, Kahn JR, Shumway NP. Preparation and function of hypertensin-converting enzyme. J Exp Med 1956;103:295-9.
84. [84] Stein PL, Vogel H, Soriano P. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev 1994;8:1999-2007.
85. [85] Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, et al. Angiotensin II type la receptor deficient mice with hypotension and hyperreninemia. J Biol Chem 1995;270:18719-22.
86. [86] Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle. J Biol Chem 1989;264:526-30.
87. [87] Thomas SM, Soriano P, Imamoto A. Specific and redundant roles of Src and Fyn in organizing the cytoskeleton. Nature 1995;376:267-71.
88. [88] Tigerstedt R, Bergman PG. Niere and kreislauf. Skand Arch Physiol 1898;78:223-71.
89. [89] Turner CE, Pietras KM, Taylor DS, Molloy CJ. Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci 1995;108:333-42.
90. [90] Ushio-Fukai M, Griendling KK, Akers M, Lyons PR, Alexander RW. Temporal dispersion of activation of phospholipase C-β1 and -γ isoforms by angiotensin II in vascular smooth muscle cells. J Biol Chem 1998;273:19772-7.
91. q coupling by the use of receptor chimeras. J Biol Chem 1995;270:16677-82.
92. [92] Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. New Engl J Med 1991;325:1688-95.
93. [93] Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM. In vivo pharmacology of Dup753. Am J Hypertens 1991;4:288S-98S.